Correction to: Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-b type II receptor (Laboratory Investigation, (2012), 92, 11, (1583-1596), 10.1038/labinvest.2012.127);Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-β type II receptor

Laboratory Investigation

Volumn 92, Issue 11, 2012, Pages 1583-1596

  Noh, Hyunjin ^a   Kim, Hyun J ^a   Yu, Mi R ^a   Kim, Wan Young ^b   Kim, Jin ^b   Ryu, Jung H ^a   Kwon, Soon H ^a   Jeon, Jin S ^a   Han, Dong C ^a   Ziyadeh, Fuad ^c  

^a Soonchunhyang University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

heat shock protein 90; renal fibrosis; Smurf2; TGF type II receptor; ubiquitin proteasome

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA SMOOTH MUSCLE ACTIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COLLAGEN TYPE 1; FIBRONECTIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SMAD2 PROTEIN; SMALL INTERFERING RNA; TANESPIMYCIN; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; URETER OBSTRUCTION;

EID: 84868553748     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/s41374-021-00705-3     Document Type: Erratum

References (38)

1. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010;6: 643-656.
2. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. J Clin Invest 2011;121: 468-474.
3. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-350. (Pubitemid 34847966)
4. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002;13:2600-2610.
5. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213-217. (Pubitemid 43323069)
6. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783-2810. (Pubitemid 41739965)
7. Feng X-H, Derynck R. Specificity and versatility in TGF-beta signaling through Smads. Ann Rev Cell Dev Biol 2005;21:659-693. (Pubitemid 41740650)
8. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577-584. (Pubitemid 37280136)
9. Kattla JJ, Carew RM, Heljic M, et al. Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 2008;295:F215-F225.
10. Rhyu DY, Yang Y, Ha H, et al. Role of reactive oxygen species in TGFbeta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005;16:667-675. (Pubitemid 41725103)
11. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 2003;228:111-133. (Pubitemid 36187918)
12. Isaacs JS, Xu W, Neckers L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 2003;3:213-217. (Pubitemid 37443877)
13. Kamal A, Thao L, Sensintaffar J, et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003; 425:407-410. (Pubitemid 37187270)
14. Porter JR, Fritz CC, Depew KM. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr Opin Chem Biol 2010;14:412-420.
15. Wrighton KH, Lin X, Feng X-H. Critical regulation of TGFbeta signaling by Hsp90. Proc Natl Acad Sci 2008;105:9244-9249.
16. Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation. Mol Cell 2000;6:1365-1375. (Pubitemid 32045929)
17. Auluck PK, Bonini NM. Pharmacological prevention of Parkinson disease in drosophila. Nat Med 2002;8:1185-1186. (Pubitemid 35373534)
18. Lu A, Ran R, Parmentier-Batteur S, et al. Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem 2002;81:355-364. (Pubitemid 34809361)
19. Murphy P, Sharp A, Shin J, et al. Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J Neurosci Res 2002; 67:461-470. (Pubitemid 34117116)
20. Waza M, Adachi H, Katsuno M, et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration Nat Med 2005;11:1088-1095. (Pubitemid 41486831)
21. Schnaper HW, Hayashida T, Hubchak SC, et al. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003;284:F243-F252. (Pubitemid 36114687)
22. Liu N, Tolbert E, Pang M, et al. Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol 2011;22:1064-1075.
23. Wang S, Wilkes MC, Leof EB, et al. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005;19:1-11. (Pubitemid 40069914)
24. Li Y, Tan X, Dai C, et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009;20:1907-1918.
25. Sharma K, Jin Y, Guo J, et al. Neutralization of TGF-beta by anti-TGFbeta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996;45:522-530.
26. Border WA, Okuda S, Languino LR, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta1. Nature 1990;346:371-374.
27. Han DC, Hoffman BB, Hong SW, et al. Therapy with antisense TGFbeta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 2000;278: F628-F634. (Pubitemid 30215241)
28. Wang W, Huang XR, Li AG, et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005;16:1371-1383. (Pubitemid 41716521)
29. Isono M, Mogyorosi A, Han DC, et al. Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol Renal Physiol 2000;278:F830-F838. (Pubitemid 30351086)
30. Hong SW, Isono M, Chen S, et al. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 2001;158:1653-1663. (Pubitemid 32422930)
31. Kang JS, Liu C, Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009;19:385-394.
32. Kang JS, Saunier EF, Akhurst RJ, et al. The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nat Cell Biol 2008; 10:654-664. (Pubitemid 351772931)
33. D'Azzo A, Bongiovanni A, Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 2005;6: 429-441. (Pubitemid 40740384)
34. Ebisawa T, Fukuchi M, Murakami G, et al. Smurf1 Interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001;276: 12477-12480.
35. Yamashita M, Ying S-X, Zhang G-m, et al. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005;121:101-113.
36. Balendran A, Casamayor A, Deak M, et al. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 1999;9:393-404. (Pubitemid 29205782)
37. Fujita N, Sato S, Ishida A, et al. Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1. J Biol Chem 2002;277:10346-10353. (Pubitemid 34968152)
38. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3betamediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931-940. (Pubitemid 39359846)